drugset / Trial / NCT00826280
Caffeine's Effect on Regadenoson Administration With Single Photon Emission Computed Tomography (SPECT) Myocardial Perfusion Imaging (MPI)
RandomizedParallel-groupQuadruple-blindDiagnostic
Summary
Observe whether the administration of caffeine prior to regadenoson will affect the interpretation of test results in subjects with coronary artery disease (CAD) undergoing SPECT MPI
Timeline
- Start
- 2009-03-24
- Primary completion
- 2010-07-15
- Completion
- 2010-07-15
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Caffeine | Small molecule | 200 mg | Oral |
| Subject | Caffeine | Small molecule | 400 mg | Oral |
| Background | Regadenoson | Diagnostic / imaging agent | 0.4 mg | Intravenous |